Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -65.18% is 18% above its 5-year average of -79.45%, around the middle of its 5-year range (-204.82%–18.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.20% below its 12-month average of -60.80%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -65.18%.
RETURN ON EQUITY (ROE)
-65.18%
RETURN ON EQUITY (ROE) AVG TTM
-60.80%
RETURN ON EQUITY (ROE) AVG 3Y
-58.11%
RETURN ON EQUITY (ROE) AVG 5Y
-79.45%
RETURN ON EQUITY (ROE) AVG 10Y
-89.11%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.20%
CURRENT VS 3Y AVG
-12.15%
CURRENT VS 5Y AVG
+17.97%
CURRENT VS 10Y AVG
+26.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.21%
median of 529 covered companies
CURRENT VS SECTOR MEDIAN
-62.09%
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.30M
Return on Equity (ROE)
-65.18%
TTM Avg
-60.80%
3Y Avg
-58.11%
5Y Avg
-79.45%
Market Cap
$11.04M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
Market Cap
$11.01M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
Market Cap
$11.38M
Return on Equity (ROE)
-177.35%
TTM Avg
-89.62%
3Y Avg
-75.99%
5Y Avg
-59.80%
Market Cap
$11.42M
Return on Equity (ROE)
-37052.06%
TTM Avg
-237.80%
3Y Avg
-258.91%
5Y Avg
-310.30%
Market Cap
$10.81M
Return on Equity (ROE)
-477.54%
TTM Avg
-207.60%
3Y Avg
64.51%
5Y Avg
-22.91%
Market Cap
$10.75M
Return on Equity (ROE)
N/A
TTM Avg
-43.97%
3Y Avg
-160.70%
5Y Avg
-188.29%
Market Cap
$11.67M
Return on Equity (ROE)
-85.82%
TTM Avg
-222.53%
3Y Avg
-140.00%
5Y Avg
-73.12%
Market Cap
$10.15M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.30M | -65.18% | -60.80% | -58.11% | -79.45% |
| Biofrontera Inc. (BFRI)vs › | $11.04M | -106.87% | -250.57% | -230.96% | -240.83% |
| BioVie Inc. (BIVI)vs › | $11.01M | -214.92% | -46.13% | -156.76% | -652.77% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | -177.35% | -89.62% | -75.99% | -59.80% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | -37052.06% | -237.80% | -258.91% | -310.30% |
| Cerenome, Inc. (CNSY)vs › | $10.81M | -477.54% | -207.60% | 64.51% | -22.91% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.75M | N/A | -43.97% | -160.70% | -188.29% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.67M | -85.82% | -222.53% | -140.00% | -73.12% |
| Lifeward Ltd. (LFWD)vs › | $10.15M | -252.37% | -195.20% | -116.68% | -90.09% |
| Lantern Pharma Inc. (LTRN)vs › | $11.81M | N/A | -180.04% | -6461.50% | -4315.55% |
ROE
-65.2%
ROA
-46.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -65.18% |
| 2026-03-31 | -79.37% |
| 2025-12-31 | -67.19% |
| 2025-09-30 | -38.12% |
| 2025-06-30 | -54.15% |
| 2025-03-31 | -50.85% |
| 2024-12-31 | 13.95% |
| 2024-09-30 | 18.48% |
| 2024-06-30 | 9.67% |
| 2024-03-31 | 8.04% |
| 2023-12-31 | -204.82% |
| 2023-09-30 | -157.25% |
| 2023-06-30 | -88.70% |
| 2023-03-31 | -117.05% |
| 2022-12-31 | -119.08% |
| 2022-09-30 | -160.04% |
| 2022-06-30 | -168.39% |
| 2022-03-31 | -132.32% |
| 2021-12-31 | -91.52% |
| 2021-09-30 | -50.58% |
| 2021-06-30 | -74.10% |
| 2021-03-31 | -54.55% |
| 2020-12-31 | -70.52% |
| 2020-09-30 | -140.54% |
| 2020-06-30 | -125.67% |
| 2020-03-31 | -106.46% |
| 2019-12-31 | -107.16% |
| 2019-09-30 | -132.83% |
| 2019-06-30 | -78.12% |
| 2019-03-31 | -75.32% |
| 2018-12-31 | -120.98% |
| 2018-09-30 | -100.13% |
| 2018-06-30 | -89.54% |
| 2018-03-31 | -240.20% |
| 2017-06-30 | -291.62% |
| 2016-09-30 | -380.00% |
| 2016-06-30 | -159.41% |
| 2016-03-31 | -120.44% |
| 2015-12-31 | -137.89% |
| 2015-09-30 | -70.53% |
| 2015-06-30 | -487.52% |
| 2015-03-31 | -169.53% |
